MFC Guide Flags Compounded vs Health Canada-Approved MHT Costs

The Menopause Foundation of Canada, with its Medical Advisory Board, has published a guide titled How to Assess Virtual and Private Menopause Clinics that directs Canadian women to ask virtual providers who is delivering care, what qualifications they hold, what services a paid fee includes, and whether recommended therapies align with Canadian and international guidelines.

Why the guidance matters for pricing

The foundation states that virtual and private menopause clinics are growing across Canada and that some services require out-of-pocket payment, which raises transparency questions for women comparing options. The guide asks women to evaluate how costs are structured, whether follow-up support is included, and whether the clinic coordinates with a regular healthcare provider.

Compounded products vs Health Canada-approved therapies

A central pricing distinction highlighted in the document is the difference between compounded products, often marketed as bioidentical hormone therapy, and Health Canada-approved therapies, which the foundation notes are regulated differently from unregulated compounded products. The guide also flags that some clinics may ask women to purchase hormone level tests, and it points readers to what clinical guidelines say about the value of such tests.

For price comparison, this distinction matters: Health Canada-approved products such as the estradiol patch pricing, estradiol gel pricing, oral estradiol pricing, progesterone pricing and vaginal estrogen pricing carry Drug Identification Numbers and posted pharmacy prices, while compounded formulations are priced individually by the compounding pharmacy and are not directly comparable.

Virtual clinic landscape in Canada

The virtual women's health category the foundation is addressing includes providers such as Coral Women's Virtual Clinic, which describes its offering as an evidence-based, customized care plan built from a patient's symptoms, health history, blood work and lifestyle habits. Teladoc Health Canada also lists gynecology and menopause among the women's health areas it covers, with services that vary depending on employer and insurer. Because coverage varies by plan, out-of-pocket exposure for medications tied to a virtual visit differs from patient to patient.

Context: telemedicine and menopause care in Canada

Peer-reviewed work on telemedicine and women's health notes that a study was conducted during the first wave of the COVID-19 pandemic at the Menopause Clinic at Mount Sinai Hospital in Toronto to assess patient satisfaction with telephone visits for menopause care and factors associated with visit-type preference. The same review flags reimbursement policy and e-prescribing rules as recurring challenges for telehealth, both of which shape what patients ultimately pay.

Questions the guide suggests asking on cost

• What is included in any listed fee, and what triggers additional charges?
• What are the clinician's menopause qualifications?
• Are proposed therapies consistent with Canadian and international guidelines?
• Is follow-up support and coordination with your regular healthcare provider offered?
• What is the rationale for any tests or therapies suggested, including hormone level checks?

What Canadian patients can compare on their own

For Health Canada-approved products dispensed through Canadian pharmacies, patients can look up posted prices and provincial coverage status before or after a virtual consultation. See our Premarin pricing, Ontario coverage reference, our online menopause treatment directory, and ongoing women's health news coverage. Compounded formulations fall outside standard formulary listings and are priced case-by-case by the dispensing compounding pharmacy.

This article is for informational purposes only and does not constitute medical advice.

Sources

• Virtual Care Assessment Tool
• Coral Women's Virtual Clinic
• Women's Health
• Full article: Telemedicine and women's health